Data revealed for the first time showcasing the company’s revolutionary wearable hydration sensor—a minimally-invasive patch that accurately detects hydration levels, delivering results, and outperforming the needle-based ‘gold standard’.
WearOptimo, a healthcare technology company developing next-generation Microwearable sensors for hydration and biomarker monitoring, today presented for the first time its formal clinical trial data for its intelligent wearable hydration technology at the LSI USA ’25 Emerging Medtech Summit in Dana Point, CA.
The data presented are part of a clinical research study which took place at Queensland University of Technology (under formal human ethics), and evaluated the ability of WearOptimo’s Microwearable Hydration sensor to detect levels of hydration compared to existing clinical protocols for measuring hydration; such as, serum osmolarity (via needle-based blood draws), mass loss and specific gravity of urine. The study was intended to demonstrate that WearOptimo’s hydration sensor is much better at detecting mild dehydration, compared to these existing tests. The clinical study was performed across 90 participant sessions. The data show that WearOptimo’s Hydration Microwearable sensors outperformed the ‘gold standard’ of serum osmolality (achieved via blood draws), demonstrating significantly greater accuracy (i.e. sensitivity and selectivity) at the typically hard to measure levels of mild dehydration.
Furthermore, the Hydration Microwearables achieved this improvement with:
- Pain-free and without any local skin interactions A newly established ‘intelligent sensor’, with our AI/machine learning and sensor technology stack generalizing to new participants.
- A form function translatable to effective productization.
“The data observed with our Microwearable marks a significant breakthrough in hydration monitoring. To our knowledge, this is the only clinically proven wearable sensor capable of accurately monitoring hydration,” said Dr. Mark Kendall, CEO and Founder of WearOptimo. “Through sophisticated engineering, we have developed a minimally-invasive wearable featuring microelectrodes that generate ultra-high-fidelity signals, amplified by advanced AI and data analytics. This technological breakthrough has allowed us to create the first clinical digital biomarker for hydration monitoring. The Microwearable sensor has significant potential to transform the way we address a multitude of ‘mis-hydration’ problems – including chronic mild dehydration, an often-overlooked health challenge linked to a 21% increase in mortality rates. Looking ahead, we are advancing our hydration Microwearable sensor for real-time, continuous monitoring, in a simple, user-friendly wearable product format. Doing so will be a step-change over the gold standard blood assay requiring a centralized laboratory, providing the results hours and days after the blood draws from a needle. Further, WearOptimo is positioned to make our sensor products at our state-of-the-art advanced manufacturing facility, with these results playing a key role in establishing a dominant market presence and reinforcing our position as a leader in wearable health technology.”
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!